IMV Inc IMVIF

What’s behind Fridays move?

[qwerty22]

and the vol in the US?

[europe10]

Qwerty, I was asking myself the same question. Merck recently bought VelosBio that had good results for  DLBCL, according to post from Breakthrough. And IMV will present results Nov 12th that might attract attention. But if Merck bought a competitior......

[Staypatient]

Maybe a sign that the stock's moving on from the Covid hype to where the real interest should lie? That wouldn't be a bad thing.

[europe10]

Maybe the COVID hype after all?? The virus has mutated in Denmark (mink farms) and that virus is spreading making AstraZeneca vaccin and others useless??? Only the ones working aginst several epitopes like IMV's can take are of a mutated virus?? Amateur speculation on my part

[antisense]

Yah that's not how mutations work.  Theres no way for any of these companies to predict which mutation will occur.  When IMV created there epitope profile the virus had not yet mutated.  So it doesn't matter how many epitopes IMV targeted at the time prior to mutation. So it's more about after each mutation which vaccine will still be effective.  If this virus has

[Staypatient]

Hardly amateur speculation. If anything a bit too sophisticated if it's the normal Friday buyers